| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.089 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |